Exelixis Layoffs and New Cancer Treatments
Kilder
- Fiercebiotech: UPDATED: Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing - Fierce Biotech
- Fiercebiotech: Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen - Fierce Biotech
- Biospace: J&J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data - BioSpace
- Biospace: Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards - BioSpace
- Bioworld: Deciphera Pharmaceuticals patents new ULK1 and ULK2 inhibitors - BioWorld MedTech
- Bioworld: Haisco Pharmaceutical describes new PARP-1 inhibitors - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.